MedPath

A study on feasibility and safety of intensity-modulated radiotherapy after lung-sparing surgery for malignant pleural mesothelioma

Not Applicable
Recruiting
Conditions
Malignant pleural mesothelioma
Registration Number
JPRN-UMIN000045496
Lead Sponsor
Kyoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

- Synchronous cancer or metachronous cancer with disease-free interval less than 5 years - A history of thoracic radiotherapy - Obvious pulmonary fibrosis and interstitial pneumonia - Serious cardiac disease, serious arrhythmia, serious infectious disease, neuropsychiatric disease - Diabetes mellitus difficult to control, or diseases requiring steroids - Patients who have difficulty in understanding the consent document or in expressing their intention to receive treatment - Other cases deemed inappropriate by the principal investigator/investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath